
### [MONDO:0020066](http://purl.obolibrary.org/obo/MONDO_0020066)
**Label:** Ehlers-Danlos syndrome

**Subclasses:** [MONDO:0017314](http://purl.obolibrary.org/obo/MONDO_0017314) (Ehlers-Danlos syndrome, vascular type), [MONDO:0016469](http://purl.obolibrary.org/obo/MONDO_0016469) (Ehlers-Danlos syndrome, vascular-like type), [MONDO:0011670](http://purl.obolibrary.org/obo/MONDO_0011670) (Ehlers-Danlos syndrome due to tenascin-X deficiency), [MONDO:0016002](http://purl.obolibrary.org/obo/MONDO_0016002) (Ehlers-Danlos syndrome, kyphoscoliotic type), [MONDO:0009158](http://purl.obolibrary.org/obo/MONDO_0009158) (Ehlers-Danlos syndrome, fibronectinemic type), [MONDO:0009159](http://purl.obolibrary.org/obo/MONDO_0009159) (Ehlers-Danlos syndrome, cardiac valvular type), [MONDO:0020521](http://purl.obolibrary.org/obo/MONDO_0020521) (Ehlers-Danlos syndrome type 7A), [MONDO:0020522](http://purl.obolibrary.org/obo/MONDO_0020522) (Ehlers-Danlos syndrome type 7B), [MONDO:0007528](http://purl.obolibrary.org/obo/MONDO_0007528) (Ehlers-Danlos syndrome, autosomal dominant, type unspecified), [MONDO:0007527](http://purl.obolibrary.org/obo/MONDO_0007527) (Ehlers-Danlos syndrome, periodontitis type), [MONDO:0007526](http://purl.obolibrary.org/obo/MONDO_0007526) (Ehlers-Danlos syndrome progeroid type), [MONDO:0007525](http://purl.obolibrary.org/obo/MONDO_0007525) (Ehlers-Danlos syndrome, arthrochalasis type), [MONDO:0007524](http://purl.obolibrary.org/obo/MONDO_0007524) (autosomal dominant Ehlers-Danlos syndrome, vascular type), [MONDO:0002014](http://purl.obolibrary.org/obo/MONDO_0002014) (autosomal recessive Ehlers-Danlos syndrome, vascular type), [MONDO:0007842](http://purl.obolibrary.org/obo/MONDO_0007842) (Ehlers-Danlos syndrome type 11), [MONDO:0007523](http://purl.obolibrary.org/obo/MONDO_0007523) (type III Ehlers-Danlos syndrome), [MONDO:0007522](http://purl.obolibrary.org/obo/MONDO_0007522) (Ehlers-Danlos syndrome, classic type), [MONDO:0010586](http://purl.obolibrary.org/obo/MONDO_0010586) (X-linked Ehlers-Danlos syndrome), [MONDO:0009161](http://purl.obolibrary.org/obo/MONDO_0009161) (Ehlers-Danlos syndrome, dermatosparaxis type), [MONDO:0019348](http://purl.obolibrary.org/obo/MONDO_0019348) (Ehlers-Danlos syndrome with periventricular heterotopia), [MONDO:0019568](http://purl.obolibrary.org/obo/MONDO_0019568) (Ehlers-Danlos syndrome type 2), [MONDO:0014236](http://purl.obolibrary.org/obo/MONDO_0014236) (Ehlers-Danlos syndrome, musculocontractural type 2), [MONDO:0009242](http://purl.obolibrary.org/obo/MONDO_0009242) (brittle cornea syndrome), [MONDO:0019567](http://purl.obolibrary.org/obo/MONDO_0019567) (Ehlers-Danlos syndrome type 1), [MONDO:0011142](http://purl.obolibrary.org/obo/MONDO_0011142) (Ehlers-Danlos syndrome, musculocontractural type), [MONDO:0016470](http://purl.obolibrary.org/obo/MONDO_0016470) (Ehlers-Danlos/osteogenesis imperfecta syndrome), [MONDO:0013605](http://purl.obolibrary.org/obo/MONDO_0013605) (brittle cornea syndrome 2), [MONDO:0012873](http://purl.obolibrary.org/obo/MONDO_0012873) (Ehlers-Danlos syndrome, spondylocheirodysplastic type), [MONDO:0012114](http://purl.obolibrary.org/obo/MONDO_0012114) (Ehlers-Danlos syndrome, Beasley-Cohen type), [MONDO:0014139](http://purl.obolibrary.org/obo/MONDO_0014139) (Ehlers-Danlos syndrome, progeroid type, 2), [MONDO:0014954](http://purl.obolibrary.org/obo/MONDO_0014954) (Ehlers-Danlos syndrome, periodontal type 2 Edspd2), [MONDO:0013800](http://purl.obolibrary.org/obo/MONDO_0013800) (Ehlers-Danlos syndrome, kyphoscoliotic and deafness type), 

**Mapped go classes:** [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0045887](http://purl.obolibrary.org/obo/GO_0045887) (positive regulation of synaptic growth at neuromuscular junction), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0006956](http://purl.obolibrary.org/obo/GO_0006956) (complement activation), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0030145](http://purl.obolibrary.org/obo/GO_0030145) (manganese ion binding), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0061448](http://purl.obolibrary.org/obo/GO_0061448) (connective tissue development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0018149](http://purl.obolibrary.org/obo/GO_0018149) (peptide cross-linking), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0061077](http://purl.obolibrary.org/obo/GO_0061077) (chaperone-mediated protein folding), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0046873](http://purl.obolibrary.org/obo/GO_0046873) (metal ion transmembrane transporter activity), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0060828](http://purl.obolibrary.org/obo/GO_0060828) (regulation of canonical Wnt signaling pathway), [GO:0030001](http://purl.obolibrary.org/obo/GO_0030001) (metal ion transport), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:2001223](http://purl.obolibrary.org/obo/GO_2001223) (negative regulation of neuron migration), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0035250](http://purl.obolibrary.org/obo/GO_0035250) (UDP-galactosyltransferase activity), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0005583](http://purl.obolibrary.org/obo/GO_0005583) (fibrillar collagen trimer), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0005586](http://purl.obolibrary.org/obo/GO_0005586) (collagen type III trimer), [GO:0046525](http://purl.obolibrary.org/obo/GO_0046525) (xylosylprotein 4-beta-galactosyltransferase activity), [GO:0060414](http://purl.obolibrary.org/obo/GO_0060414) (aorta smooth muscle tissue morphogenesis), [GO:0005588](http://purl.obolibrary.org/obo/GO_0005588) (collagen type V trimer), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0047220](http://purl.obolibrary.org/obo/GO_0047220) (galactosylxylosylprotein 3-beta-galactosyltransferase activity), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0003831](http://purl.obolibrary.org/obo/GO_0003831) (beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0030517](http://purl.obolibrary.org/obo/GO_0030517) (negative regulation of axon extension), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006829](http://purl.obolibrary.org/obo/GO_0006829) (zinc II ion transport), [GO:0001537](http://purl.obolibrary.org/obo/GO_0001537) (N-acetylgalactosamine 4-O-sulfotransferase activity), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0006882](http://purl.obolibrary.org/obo/GO_0006882) (cellular zinc ion homeostasis), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:0006487](http://purl.obolibrary.org/obo/GO_0006487) (protein N-linked glycosylation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0008146](http://purl.obolibrary.org/obo/GO_0008146) (sulfotransferase activity), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0005797](http://purl.obolibrary.org/obo/GO_0005797) (Golgi medial cisterna), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0016051](http://purl.obolibrary.org/obo/GO_0016051) (carbohydrate biosynthetic process), [GO:0001867](http://purl.obolibrary.org/obo/GO_0001867) (complement activation, lectin pathway), [GO:0014814](http://purl.obolibrary.org/obo/GO_0014814) (axon regeneration at neuromuscular junction), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0071577](http://purl.obolibrary.org/obo/GO_0071577) (zinc II ion transmembrane transport), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:2000050](http://purl.obolibrary.org/obo/GO_2000050) (regulation of non-canonical Wnt signaling pathway), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0021987](http://purl.obolibrary.org/obo/GO_0021987) (cerebral cortex development), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0047757](http://purl.obolibrary.org/obo/GO_0047757) (chondroitin-glucuronate 5-epimerase activity), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0030574](http://purl.obolibrary.org/obo/GO_0030574) (collagen catabolic process), [GO:0034097](http://purl.obolibrary.org/obo/GO_0034097) (response to cytokine), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:1903225](http://purl.obolibrary.org/obo/GO_1903225) (negative regulation of endodermal cell differentiation), [GO:0009612](http://purl.obolibrary.org/obo/GO_0009612) (response to mechanical stimulus), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0030208](http://purl.obolibrary.org/obo/GO_0030208) (dermatan sulfate biosynthetic process), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0005528](http://purl.obolibrary.org/obo/GO_0005528) (FK506 binding), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0050777](http://purl.obolibrary.org/obo/GO_0050777) (negative regulation of immune response), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0050655](http://purl.obolibrary.org/obo/GO_0050655) (dermatan sulfate proteoglycan metabolic process), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0005385](http://purl.obolibrary.org/obo/GO_0005385) (zinc ion transmembrane transporter activity), [GO:0008378](http://purl.obolibrary.org/obo/GO_0008378) (galactosyltransferase activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008499](http://purl.obolibrary.org/obo/GO_0008499) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0046332](http://purl.obolibrary.org/obo/GO_0046332) (SMAD binding), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0097435](http://purl.obolibrary.org/obo/GO_0097435) (supramolecular fiber organization), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 54.14%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.19%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.19%
- [GO:0005588](http://purl.obolibrary.org/obo/GO_0005588) (collagen type V trimer) 51.19%
- [GO:0005586](http://purl.obolibrary.org/obo/GO_0005586) (collagen type III trimer) 51.19%
- [GO:0005583](http://purl.obolibrary.org/obo/GO_0005583) (fibrillar collagen trimer) 37.74%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.55%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.55%
- [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 30.06%
- [GO:0043227](http://purl.obolibrary.org/obo/GO_0043227) (membrane-bounded organelle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 30.06%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 30.02%
- [GO:0044421](http://purl.obolibrary.org/obo/GO_0044421) (extracellular region part) 23.33%
- [GO:0044420](http://purl.obolibrary.org/obo/GO_0044420) (extracellular matrix component) 22.79%
- [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) 19.94%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 13.25%


